Week ending Friday, October 30, 2026 · Published by QuantLogix Research
A dispersed, earnings-driven tape saw the S&P 500 close within 3% of its record while the Nasdaq slid on an Alphabet-led Comm Services rout. The Fed held rates at 3.75–4.00% in a hawkish 10–2 vote with two dissents preferring a hike, forcing a reset in forward curves. Defense primes extended their earnings-season leadership, Health Care printed fresh highs, and Mag-7 cap-ex math remains the market's dominant debate heading into Apple and Nvidia prints.
Approximate end-of-week prints; weekly % tracks Friday-to-Friday close. Breadth improved despite the headline weakness: 64% of S&P 500 constituents closed higher on the week, with 9 of 11 sectors advancing. The index-level weakness was concentrated in one cohort — mega-cap Comm Services — while the median stock traded well. The S&P 500 remains ~3% below its all-time high.
Health Care led as GLP-1 franchise strength and managed-care tape kept defensive flows constructive. Materials followed on copper and specialty chem beats. Comm Services took the week's full damage from Alphabet's post-earnings drop. YTD leadership belongs to Energy (+56.6%); the lagging sector is Comm Services (−15.1%).
The FOMC left the fed funds target range at 3.75–4.00% on Wednesday, as expected on headline but with a hawkish lean beneath. The 10–2 vote showed two dissents — Governor Lisa Cook and Cleveland Fed President Beth Hammack — preferring a 25bps hike, not a cut. The statement upgraded the economic assessment to “strong” from September's “solid” and said inflation “remains elevated,” with policy to be guided by “the accumulation of more information.”
The press conference struck a measured tone. Chair Kevin Warsh acknowledged conditions had tightened for “some businesses and households” but was unwilling to call financial conditions tight overall. Analysts described the forward guidance as “decidedly vague” — which is itself a hawkish signal when markets had entered the meeting pricing a ~70% cut probability earlier in October.
Macro data confirmed the committee's stance. Q3 GDP printed 3.4% (vs. 3.2% expected; prior 2.2%), Core PCE was in-line at 3.1% YoY and 0.3% MoM, and Consumer Confidence blew out at 91.7 vs. 81.2 expected. Jobless claims fell to 194K vs. 198K forecast. The hard-data pulse is anything but recessionary.
The December-meeting curve has repriced hawkishly: our cut-probability nowcaster collapsed from 55% to 18% over the week, while a 25bps HIKE probability for December climbed to roughly 35% — a stunning two-week swing. Our regime model has shifted to Hot Growth / Sticky Inflation, historically a mixed environment for duration and a tailwind for cyclicals, defense and value. The next Oct NFP print on Friday will decide whether this hawkish reset holds.
If last week was about defense primes passing their test, this week was about mega-cap tech failing to clear a very high bar. Alphabet (GOOGL) was the story: Q3 cloud revenue roughly doubled, but Search ad revenue missed and AI infrastructure cap-ex guidance stepped meaningfully higher — a toxic combination that the market punished with a −12% weekly drop, the sharpest since the 2022 ad reset. Microsoft's print beat but offered no relief on cap-ex trajectory; shares eased −1.1%. Meta Platforms traded −3.4% as its own AI-infrastructure numbers crossed a threshold where investors began to haircut per-share earnings power.
The deeper issue is intertwined: Big Tech's combined Q4 cap-ex guidance now implies >$600B of annual AI infrastructure spending, with payback-period math that no longer closes under traditional cloud-economics models. Nvidia's November 19 print is now the single most important data event of Q4. Any Blackwell/Rubin visibility weakness would validate the funding-math anxiety; a decisive beat snaps the narrative. Supplier color from AMD's Nov 4 print and Marvell's Dec 3 call will set the backdrop.
Beneath the mega-caps, dispersion remained extreme. Reddit (-36.4%), ServiceNow (-33.9%), and F5 (-25.7%) led the S&P's worst-weekly-performer list on self-inflicted guidance disappointments, while Vertiv (+19.6%), Pentair (+19.8%) and Carvana (+18.1%) led the gainers. The retail unwind in AI-infrastructure positioning has not finished.
| Name | WoW |
|---|---|
| GOOGL Alphabet | −12.0% |
| RDDT | −36.4% |
| NOW ServiceNow | −33.9% |
| META Meta Platforms | −3.4% |
| MSFT Microsoft | −1.1% |
| NVDA Nvidia | −2.6% |
| AMD AMD | +1.8% |
| AMZN Amazon | +2.1% |
| VRT Vertiv | +19.6% |
| CRWV CoreWeave | −5.9% |
The defense cohort extended the leadership it won last week. All five majors that reported this cycle beat on both revenue and EPS; three raised full-year guidance; two posted record backlogs. Lockheed Martin (LMT) added another +2.1% after last week's +6.4%, consolidating gains as F-35 sustainment, PAC-3 throughput and classified Space revenues powered through. RTX added +3.4% on Collins Aerospace and Pratt & Whitney order flow; Northrop Grumman gained +2.5% on B-21 production milestones; General Dynamics firmed +1.9%.
The signal beneath the headline is the capital-return cadence. Four of the top five primes announced buyback authorizations and dividend increases on this earnings cycle, consistent with cash-conversion acceleration post-FY26 appropriations. The ITA aerospace & defense ETF closed the week +2.4%, decoupling cleanly from the broader tape.
Palantir (PLTR) rebounded +4.0% ahead of its Nov 3 earnings print, with elevated option skew implying a ~12% move. The AIP commercial ramp and TITAN army program trajectory remain the two debates. Smaller specialists — Kratos (KTOS), Mercury Systems (MRCY), AeroVironment (AVAV) — also finished green on contract-flow headlines.
Defense factor remains Overweight. The geopolitical-stress composite stayed above the 70th percentile all week; Pentagon contract-flow nowcaster accelerated to +14% YoY, the strongest since 2022. Book-to-bill across the top four primes expanded to 1.25. The subsector's relative strength vs. the S&P 500 widened to +10.8% over 90 days. Primary risks are a sharp de-escalation thesis and an FY27 continuing-resolution standoff.
| Name | WoW |
|---|---|
| PLTR Palantir | +4.0% |
| RTX RTX Corp. | +3.4% |
| NOC Northrop Grumman | +2.5% |
| ITA iShares A&D ETF | +2.4% |
| LMT Lockheed Martin | +2.1% |
| GD General Dynamics | +1.9% |
| LHX L3Harris | +1.4% |
| KTOS Kratos | +3.8% |
| AVAV AeroVironment | +5.2% |
The S&P 500 Health Care sector (XLV) printed a fresh all-time high on Thursday, closing the week +3.1% — the best print in the GICS table. Managed care, large-cap pharma and medical devices all contributed; dispersion within biotech remained extreme but ended on a constructive foot.
Eli Lilly (LLY) added +2.1% on sustained GLP-1 franchise commentary and physician-script data; the obesity thematic kept its grip on defensive flows. Novo Nordisk (NVO) rebounded +3.5% after a tough start to the quarter, buoyed by positive Phase 3 CagriSema readout chatter. UnitedHealth (UNH) firmed another +1.4% on calmer MLR commentary from Centene and Humana prints. Johnson & Johnson and Merck both logged modest green weeks.
In biotech proper, Moderna (MRNA) rallied +6.2% into its melanoma-vaccine Phase 3 readout window; Regeneron (REGN) rallied +4.1% post-Q3 beat on EYLEA HD and Dupixent momentum; Vertex (VRTX) added +1.8%. Oncology ADC and molecular-glue baskets continued to attract M&A speculation; the XBI biotech ETF closed +2.3%, finally registering a positive week after three consecutive down weeks.
Our Health Care factor model has moved to Overweight, with GLP-1 ownership, managed care, and ADC/radiopharm thematic baskets as the three leadership vectors. Defensive flows into XLV should extend if the hawkish Fed reset holds; mid-cap biotech remains the credit-spread proxy worth monitoring. Risk: large-cap pharma's December PBM-pricing deadline and an election-year drug-pricing refocus.
| Name | WoW |
|---|---|
| MRNA Moderna | +6.2% |
| REGN Regeneron | +4.1% |
| NVO Novo Nordisk | +3.5% |
| XBI SPDR Biotech ETF | +2.3% |
| LLY Eli Lilly | +2.1% |
| VRTX Vertex Pharma | +1.8% |
| UNH UnitedHealth | +1.4% |
| AMGN Amgen | +1.1% |
| BNTX BioNTech | +2.9% |
| JNJ Johnson & Johnson | +0.8% |
| Company | Revenue | EPS | WoW | Notable |
|---|---|---|---|---|
| GOOGL Alphabet |
$102.4B | $2.49 | −12.0% | Cloud 2x+; Search ad miss; cap-ex guide raised ($95B FY26) |
| MSFT Microsoft |
$79.1B | $3.72 | −1.1% | Azure +34% CC; Copilot 50M MAU; AI cap-ex ramp continues |
| META Meta Platforms |
$44.7B | $7.84 | −3.4% | Ad eCPM strong; AI data-center cap-ex ratcheted higher |
| AMZN Amazon |
$168.9B | $1.72 | +2.1% | AWS +22%; retail margins expand; Trainium adoption notes |
| LMT Lockheed Martin |
$18.9B | $7.78 | +2.1% | Record backlog; raised FY guide; buyback refreshed |
| RTX RTX Corp. |
$22.4B | $1.86 | +3.4% | Collins/P&W beat; raised FY; book-to-bill 1.3 |
| LLY Eli Lilly |
$14.8B | $6.14 | +2.1% | Mounjaro/Zepbound scripts durable; GLP-1 CAGR intact |
| REGN Regeneron |
$3.9B | $12.08 | +4.1% | EYLEA HD ramp; Dupixent franchise expanding |
With roughly 300 S&P 500 companies reported, Q3 earnings growth is tracking +30% YoY (+25% ex-Energy) and 82% have beaten EPS — the strongest cohort beat since 2021. The forward P/E compression in Mag-7 is the market's single most important chart heading into Apple (Oct 31 after-hours) and Nvidia (Nov 19). Defense primes and consumer-staples defensives remain the cleanest beats.
The hawkish Fed reset pressured precious metals mid-week before dip-buying from central banks and ETF flows stabilized the complex. Gold spot closed near $4,018/oz (−2.1% WoW) — its first down week in six — but held the psychologically important $4,000 handle. YTD gold is still +51%. Silver softened to $49.10/oz; platinum and palladium traded in a tight range.
Energy continued to cool. Brent crude slid to $104.10 (−2.9% WoW) on reports of Hormuz de-escalation progress and softer China PMI commentary. WTI closed near $93.80. Nat gas drifted lower on milder weather forecasts; copper eased on dollar strength.
The dollar firmed on the hawkish Fed, with the DXY at 104.7. Yen softened to 156.4/USD on widening rate differentials; the euro drifted to 1.058 on softer eurozone industrial production. Sterling held on firmer gilt yields. Safe-haven flows into the Swiss franc stabilized after mid-week pressure.
Crypto rebounded late in the week. Bitcoin reclaimed $84,000, up +2.4% WoW on positive spot-ETF flow data and softening dollar overnight after the FOMC. Ethereum firmed to $3,214; the ETH/BTC ratio stabilized at multi-year lows. Solana outperformed on sustained L1 TVL growth; the stablecoin aggregate hit a fresh high above $250B, a key liquidity indicator.
Positioning indicators point to a reset — not a capitulation. Breadth is rebuilding beneath the Mag-7-weighted index weakness; retail sentiment surveys are stretched to the bearish side, which historically has been a contrarian support for the median stock on short horizons. The Mag-7 remains the dominant risk factor.
Three cross-currents frame the setup: (1) a hawkish Fed anchoring the long end near 5%, (2) a defense/health-care leadership tape with wide dispersion, and (3) the final leg of mega-cap earnings culminating in Nvidia on Nov 19. Position sizing matters more than directional bets — our composite risk model has moved to Mixed Regime, favoring factor diversification (quality + value + defense + GLP-1) and a tactical underweight to pure AI-infrastructure beta heading into the NVDA print.